Lincoln Pharmaceuticals Ltd. Financials

NSE BSE

15:51 Jul 18

Lincoln Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

559.40

-6.95 (-1.23%)

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

NSE BSE

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals

559.40

-6.95 (-1.23%)
15:51 Jul 18

Quality

55/100
High Financial Strength

Valuation

49/100
Mid Valuation

Technical

39/100
Technically Neutral

Strength

Weakness

Opportunity

Threats

ROE %

ROA %

EPS

BVPS

Net Profit Margin

Income Statement Balance sheet Cash flow Ratio Shareholding

Quarterly Annual

Consolidated Standalone

	Mar 2021	Mar 2022	Mar 2023	Mar 2024	Mar 2025
Net Sales	424.19	472.12	510.31	580.55	623.23
Operating Expenses +	337.01	376.64	421.1	480.65	521.74
Raw Material	193.74	232.15	245.64	284.03	282.48
Increase Decrease in Cost	3.99	-13.57	-4.24	-5.7	8.84
Other Manufacturing Expense	0	0	0	0	0
Employee Cost	60.74	70.47	93.16	102.9	112.45
Miscellaneous Expenses	219.16	234.93	223.82	265.24	255.05
Operating Profit	87.18	95.48	89.21	99.9	101.49
Other Income	5.66	10	22.47	34.42	22.48
Depreciation	7.56	8.09	9.17	10.62	12.9
Interest	1.56	1.45	2.03	1.46	1.88
Profit before tax and exceptio..	83.72	95.94	100.48	122.24	109.19
Exceptional Items	0	0	0	0	0
PBT	83.72	95.94	100.48	122.24	109.19
Provision for Taxation	21.47	26.58	27.58	28.94	26.84
Net Profit	62.25	69.36	72.9	93.3	82.35
NET Profit after MI	62.22	69.36	72.9	93.3	82.35
EPS	31.11	34.63	36.4	46.58	41.11
Operating Profit Margin (%)	20.55	20.22	17.48	17.21	16.28
Net Profit Margin (%)	14.67	14.69	14.29	16.07	13.21

All Data in Percentage (%)

	Jun 25	Mar 25	Dec 24	Sep 24	Jun 24
Promoter	49.80	49.80	49.80	49.80	49.80
FII	5.10	5.00	5.20	5.20	4.00
MF	0.00	0.00	0.00	0.00	0.00
Others	0.00	0.00	-0.10	0.00	0.00

Promoter Non-Promoter

Shareholder	Shares	Holding %

Download Our App On: